Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: A complex network of interactions influencing viral replication and AIDS pathogenesis

被引:58
作者
Fantuzzi, L [1 ]
Belardelli, F [1 ]
Gessani, S [1 ]
机构
[1] Ist Super Sanita, Virol Lab, I-00161 Rome, Italy
关键词
infection; immune mediators; regulation;
D O I
10.1189/jlb.0403175
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Monocytes/macrophages are cells of the innate arm of the immune system and exert important regulatory effects on adaptive immune response. These cells also represent major targets of HIV infection and one of the main reservoirs. Notably, macrophage-tropic viruses are responsible for the initial infection, predominate in the asymptomatic phase, and persist throughout infection, even after the emergence of dual-tropic and T-tropic variants. Functional impairment of HIV-infected macrophages plays an important role in the immune dysregulation typical of AIDS. Recent studies have underlined the pivotal role of chemokines, cytokines, and their receptors in HIV pathogenesis. It is becoming increasingly apparent that the expression level of chemokine receptors, serving as HIV coreceptors, influences the susceptibility of a CD4(+) cell to viral infection and to certain HIV envelope-induced alterations in cellular functions. Numerous pathogens, including HIV, can stimulate the production of chemokines and cytokines, which in turn can modulate coreceptor availability, resulting in differential replication potential for R5 and X4 strains, depending on the microenvironment milieu. Thus, a complex network of interactions involving immune mediators produced by monocytes/macrophages and other cell types as a direct/indirect consequence of HIV infection is operative at all stages of the disease and may profoundly influence the extent of viral replication, dissemination, and pathogenesis. J. Leukoc. Biol. 74: 719-725; 2003.
引用
收藏
页码:719 / 725
页数:7
相关论文
共 60 条
[11]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[12]   Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line [J].
Biswas, P ;
Delfanti, F ;
Bernasconi, S ;
Mengozzi, M ;
Cota, M ;
Polentarutti, N ;
Mantovani, A ;
Lazzarin, A ;
Sozzani, S ;
Poli, G .
BLOOD, 1998, 91 (01) :258-265
[13]   Divergent effects of interleukin-4 and interferon-γ on macrophage-derived chemokine Production:: An amplification circuit of polarized T helper 2 responses [J].
Bonecchi, R ;
Sozzani, S ;
Stine, JT ;
Luini, W ;
D'Amico, G ;
Allavena, P ;
Chantry, D ;
Mantovani, A .
BLOOD, 1998, 92 (08) :2668-2671
[14]   INDUCTION OF INTERLEUKIN-10 BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND ITS GP120 PROTEIN IN HUMAN MONOCYTES MACROPHAGES [J].
BORGHI, P ;
FANTUZZI, L ;
VARANO, B ;
GESSANI, S ;
PUDDU, P ;
CONTI, L ;
CAPOBIANCHI, MR ;
AMEGLIO, F ;
BELARDELLI, F .
JOURNAL OF VIROLOGY, 1995, 69 (02) :1284-1287
[15]  
Canque B, 1996, BLOOD, V87, P2011
[16]   Inhibition of HIV type 1 BaL replication by MIP-1α, MIP-1β, and RANTES in macrophages [J].
Capobianchi, MR ;
Abbate, I ;
Antonelli, G ;
Turriziani, O ;
Dolei, A ;
Dianzani, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (03) :233-240
[17]   Envelope glycoproteins of human immunodeficiency virus type 1: Profound influences on immune functions [J].
Chirmule, N ;
Pahwa, S .
MICROBIOLOGICAL REVIEWS, 1996, 60 (02) :386-+
[18]   Induction of rapid and extensive β-chemokine synthesis in macrophages by human immunodeficiency virus type 1 and gp120, independently of their coreceptor phenotype [J].
Choe, W ;
Volsky, DJ ;
Potash, ML .
JOURNAL OF VIROLOGY, 2001, 75 (22) :10738-10745
[19]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[20]  
Ciesielski CJ, 2002, EUR J IMMUNOL, V32, P2037, DOI 10.1002/1521-4141(200207)32:7<2037::AID-IMMU2037>3.0.CO